Evidence map›Paper›PMID 41813489›Full record

ArticleJMIR formative research2026

Individual Variability in Physiological Responses and Psychological Conditions Associated With Methamphetamine Use: Pilot Ecological Momentary Assessment Study Using a Wearable Device and Self-Monitoring Mobile App.

Ayumi Takano, Kayo Okuda, Jun Sese, Koki Ono, Toshihiko Matsumoto

Abstract read
In one paragraph

Article in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ayumi TakanoDepartment of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, 187-8553, Japan, 1 42-346-1861.ORCID 0000-0001-8363-1235
Kayo OkudaHumanome Lab, Inc, Tokyo, Japan.
Jun SeseHumanome Lab, Inc, Tokyo, Japan.
Koki OnoDepartment of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, 187-8553, Japan, 1 42-346-1861.ORCID 0000-0002-3296-8038
Toshihiko MatsumotoDepartment of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, 187-8553, Japan, 1 42-346-1861.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Digital mental health approaches offer a novel means to monitor and reduce harms associated with substance use in daily life. However, limited evidence exists on their application for methamphetamine (MAMP) use, particularly regarding individual variability in physiological responses and psychological conditions. Objective: This pilot study aimed to explore inter- and intraindividual differences in craving, emotion, and heart rate associated with MAMP use, using data collected from a wearable device (Fitbit) and a mobile-based self-monitoring app. Methods: Participants were individuals with MAMP use disorder receiving outpatient treatment in Japan. The analysis included 7 participants who used MAMP during an 8-week observation period. Physiological data, including heart rate and sleep patterns, were collected using Fitbit devices, while daily self-reported MAMP use, craving intensity, and emotional status were recorded via a mobile app. After syncing the data, we visualized and summarized individual MAMP use patterns in detail. Correlations between physiological and psychological indicators and the frequency of MAMP use per day were analyzed. In addition, heart rate trends before and after MAMP use events were evaluated using a linear mixed effects model, and both interindividual variability and intraindividual variability were assessed. Results: Patterns of MAMP use varied widely across participants, with it most commonly occurring in the morning or at night, regardless of the day of the week. Craving and negative emotions were frequently reported on MAMP use days and were positively correlated with the number of MAMP use episodes per day. Participants who used MAMP more frequently exhibited relatively higher resting heart rates. Following MAMP use, heart rate increased significantly and remained elevated for up to 9 hours. Sleep duration and frequency were reduced or absent on MAMP use days. Approximately 64% of the variance in heart rate was attributable to interindividual differences, while 12% reflected variability across events within the same individual. Conclusions: This pilot study demonstrates the feasibility and value of using digital tools to examine physiological responses and psychological conditions associated with MAMP use in real-world settings. Persistent cardiovascular activation and disrupted sleep highlight the potential risks of long-term MAMP use. Individual differences in heart rate responses, craving, and emotional states underscore the importance of personalized intervention strategies. Integrating real-time self-monitoring, notifications for elevated heart rate, and online cognitive behavioral therapy into digital therapeutic interventions may improve health outcomes for individuals with MAMP use disorder.

Indexed as

Amphetamine-Related DisordersMethamphetamineMobile ApplicationsWearable Electronic DevicesAdultCravingDigital HealthEcological Momentary AssessmentFemaleHeart RateHumansJapanMaleMiddle AgedPilot ProjectsMethamphetaminedigital therapeutic interventionecological momentary assessmentmethamphetaminemobile appphysiological dataself-monitoringwearable device

Identifiers

PMID41813489
PMCPMC12954691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.